Latest news

amnog-and-the-german-reforms-what-will-change

AMNOG and the German Reforms: What Will Change?

Germany is typically prioritized by the pharmaceutical industry: it remains a market with relatively high drug prices, offers extensive commercial opportunities and has an important position as an international reference country to 17 markets. The implementation of AMNOG in 2011 sought to reduce drug prices and relieve the healthcare budget, yet financial pressure remains, particularly […]

Read More


partners4access-is-pleased-to-announce-the-addition-of-jose-luis-betrian-to-the-executive-team

Partners4Access is pleased to announce the addition of Jose Luis Betrian to the executive team

Executive team strengthened to drive further launch support for the biotechnology industry. Continued focus is ‘Orphan Drug Solutions’ a partnership approach to ensuring a successful global launch. Partners4Access, the global access experts for orphan drugs, has strengthened its executive team this week with the addition of Jose Luis Betrian. Jose Luis joins as Executive Director, […]

Read More


All Rights Reserved © PARTNERS 4 ACCESS 2016